Trials / Not Yet Recruiting
Not Yet RecruitingNCT07314203
Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 118 (estimated)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Exploring the pathological complete response rate (pCR) of locally advanced gastric cancer treated with adebelimab combined or not combined with apatinib mesylate and SOX neoadjuvant therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib Mesylate Tablets | Apatinib Mesylate |
Timeline
- Start date
- 2026-12-25
- Primary completion
- 2027-08-25
- Completion
- 2028-08-25
- First posted
- 2026-01-02
- Last updated
- 2026-01-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07314203. Inclusion in this directory is not an endorsement.